Anatomic & Clinical Pathology in Santa Barbara, CA
15 verified anatomic & clinical pathology doctors in Santa Barbara.
Pathologists diagnose disease by examining tissue, blood, and other lab specimens.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Stewart Comer, MD
Anatomic & Clinical Pathology
CMS Open Payments· $16.98 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.98
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Stewart Comer do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Martin-Reay, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Richardson, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anne Drejet, MD
Anatomic & Clinical Pathology
CMS Open Payments· $21.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$21.14
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Anne Drejet do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Peter Morris, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Donna Kell, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Blaustein, MD
Anatomic & Clinical Pathology
CMS Open Payments· $10,894 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$10,894
Total received
5
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to John Blaustein do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Repik, DO
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Edward Kaufman, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Faith Ough, MD
Anatomic & Clinical Pathology
CMS Open Payments· $4,289 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$4,289
Total received
3
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Faith Ough do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Matthew Denicola, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Monica Phillips, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Emily Waterhouse, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mark Fowler, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kaitlyn Nielson, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.